LifePlan Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$714K Sell
2,811
-546
-16% -$127K 0.5% 56
2026
Q1
$821K Sell
3,357
-547
-14% -$127K 0.61% 55
2025
Q4
$808K Buy
3,904
+106
+3% +$21K 0.62% 53
2025
Q3
$704K Sell
3,798
-157
-4% -$26.9K 0.56% 58
2025
Q2
$604K Sell
3,955
-41
-1% -$6.3K 0.5% 56
2025
Q1
$663K Sell
3,996
-231
-5% -$36.1K 0.58% 52
2024
Q4
$611K Buy
4,227
+2,978
+238% +$461K 0.54% 54
2024
Q3
$202K Buy
+1,249
New +$199K 0.17% 88
2024
Q2
Sell
-1,303
Closed -$206K 93
2024
Q1
$206K Sell
1,303
-149
-10% -$23.7K 0.19% 93
2023
Q4
$228K Buy
+1,452
New +$223K 0.23% 84

Other funds holding JNJ

LifePlan Financial's JNJ Position: Q2 2026 in Review

LifePlan Financial reduced its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, selling an estimated $127K and leaving 2,811 shares worth $714K. The position accounts for 0.5% of the portfolio, ranked #56.

LifePlan Financial first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. The position peaked at $821K in Q1 2026. 2,252 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • LifePlan Financial held 2,811 shares of Johnson & Johnson worth $714K as of Q2 2026.
  • LifePlan Financial sold 546 Johnson & Johnson shares in Q2 2026, an estimated $127K.
  • Johnson & Johnson made up 0.5% of LifePlan Financial's portfolio in Q2 2026, its #56 holding.
  • LifePlan Financial first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • LifePlan Financial's Johnson & Johnson position peaked at $821K in Q1 2026.
  • 2,252 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on LifePlan Financial's 13F filing for Q2 2026, filed 21 Jul 2026.